DENTSPLY SIRONA Inc. XRAY

FY2025 · ended Dec 31, 2025 · Revenue $3.68B, -3.0% YoY · Filed Feb 26, 2026

DENTSPLY SIRONA Inc. (XRAY) files with the SEC under industry code 3843, Dental Equipment & Supplies. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $3.7 billion and a net loss of $598.0 million. Free cash flow was $104.0 million. As of Jun 30, 2026 it held $239.0 million in cash and investments and $2.1 billion in total debt.

Revenue (TTM)
$3.64B
-0.8% vs year-ago TTM
Net income (TTM)
$-546.00M
+42.5% vs year-ago TTM
Operating cash flow (TTM)
$319.00M
+12.7% vs year-ago TTM
Free cash flow (TTM)
$143.00M
+3.6% vs year-ago TTM
EPS (TTM)
$-2.73
+42.8% vs year-ago TTM
Dividend per share
$0.64
+0.0% vs prior year
Shares outstanding
199.75M
+0.4% vs prior year
Net cash
$-1.84B
as of Jun 30, 2026
Operating margin
-8.5%
FY 2026

Company profile

Industry
Dental Equipment & Supplies (SIC 3843)
Listed as
XRAY (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Charlotte, NC
SEC filer status
Large accelerated filer
SEC CIK
818479
Former names
DENTSPLY INTERNATIONAL INC /DE/ (until Feb 29, 2016)

Other Dental Equipment & Supplies companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$3.7B
$3.8B
$4.0B
$3.9B
$4.2B
Operating income
-$422.0M
-$879.0M
-$85.0M
-$937.0M
$608.0M
Net income
-$598.0M
-$910.0M
-$132.0M
-$950.0M
$411.0M
Diluted EPS
-$3.00
-$4.48
-$0.62
-$4.41
$1.87
Operating cash flow
$235.0M
$461.0M
$377.0M
$517.0M
$657.0M
Free cash flow
$104.0M
$281.0M
$228.0M
$368.0M
$515.0M
Total assets
$5.4B
$5.8B
$7.4B
$7.6B
$9.2B
Total liabilities
$4.1B
$3.8B
$4.1B
$3.8B
$4.2B
Stockholders' equity
$1.3B
$1.9B
$3.3B
$3.8B
$5.0B
Cash and investments
$326.0M
$272.0M
$334.0M
$365.0M
$339.0M
Total debt
$2.4B
$1.9B
$2.1B
$2.1B
$2.1B

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Material agreement, New debt
Oct 9, 2026 Oct 8, 2026
8-K/A Amended current report
Results of operations
Aug 7, 2026 Aug 6, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report Aug 6, 2026 Aug 6, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 11, 2026 Jun 11, 2026
8-K Current report
Shareholder vote results
Jun 4, 2026 Jun 2, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.